PLIANT THERAPEUTICS
Pliant Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Pliant's lead product candidate, PLN-74809, is an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins that it is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis, or PSC. PLN-74809 has received Orphan Drug Designation from the U.S. Food and Drug Administration for both ... IPF and PSC. Pliant is currently recruiting two Phase 2a trials of PLN-74809 for the treatment of IPF and plans to initiate a Phase 2a trial in PSC in the second half of 2020. Pliant's second product candidate, PLN-1474, is a small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis, or NASH, which Pliant has partnered with Novartis. PLN-1474 is currently undergoing a Phase 1 trial. In addition to clinical stage programs, Pliant currently has two preclinical programs targeting oncology and muscular dystrophies.
PLIANT THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics Pharmaceutical Recruiting Therapeutics
Founded:
2015-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.pliantrx.com
Total Employee:
101+
Status:
Active
Contact:
(910)509-3977
Total Funding:
694.95 M USD
Technology used in webpage:
Amazon HSTS IPv6 ReCAPTCHA V2 Amazon Virginia Region COVID-19 Ruby On Rails Token Envoy Akamai Hosted Comcast
Similar Organizations
4D Molecular Therapeutics
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
Alzheon
Alzheon is a clinical-stage biotechnology company focused on brain health, memory and aging, developing a pipeline of innovative.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Annexon Biosciences
Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.
Click Therapeutics
Click Therapeutics delivers safe and effective digital treatments to patients in need.
Cytosorbents
Cytosorbents develops therapeutic devices used in purifying blood to treat life-threatening diseases.
Found
Found is dedicated to improving people’s overall wellbeing by making evidence-based weight loss accessible and affordable.
GRO Biosciences
GRO Biosciences is a biotechnology company that expands the amino acid alphabet to overcome the limitations of protein therapeutics.
PathAI
PathAI is developing technology that assists pathologists in making rapid and accurate diagnoses for every patient, every time.
Sarepta Therapeutics
Sarepta Therapeutics focuses on the discovery and development of precision genetic medicine to treat rare diseases.
Current Advisors List
Advisor
Advisor
Board_member
Board_member
Board_member
Board_member
Board_member
Advisor
Current Employees Featured
Bernard Coulie President and Chief Executive Officer @ Pliant Therapeutics
President and Chief Executive Officer
2016-02-01
Hans Hull Chief Business Officer @ Pliant Therapeutics
Chief Business Officer
2016-03-01
Craig Muir Interim Chief Technology Officer @ Pliant Therapeutics
Interim Chief Technology Officer
Bill DeGrado Scientific Founder @ Pliant Therapeutics
Scientific Founder
Dean Sheppard Scientific Founder @ Pliant Therapeutics
Scientific Founder
Bradley Backes Scientific Founder @ Pliant Therapeutics
Scientific Founder
Hal Chapman Scientific Founder @ Pliant Therapeutics
Scientific Founder
Minnie Kuo Chief Development Officer @ Pliant Therapeutics
Chief Development Officer
2023-09-01
David Morgans Vice President of Drug Discovery and Early Development @ Pliant Therapeutics
Vice President of Drug Discovery and Early Development
Mishima Gerhart Chief Regulatory Officer @ Pliant Therapeutics
Chief Regulatory Officer
2023-10-01
Founder
Stock Details
Investors List
Novartis Institutes for Biomedical Research
Novartis Institutes for Biomedical Research investment in Series C - Pliant Therapeutics
Agent Capital
Agent Capital investment in Series C - Pliant Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Pliant Therapeutics
Logos Capital
Logos Capital investment in Series C - Pliant Therapeutics
Eventide
Eventide investment in Series C - Pliant Therapeutics
Schroder Adveq
Schroder Adveq investment in Series C - Pliant Therapeutics
S-Cubed Capital
S-Cubed Capital investment in Series C - Pliant Therapeutics
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series C - Pliant Therapeutics
Redmile Group
Redmile Group investment in Series C - Pliant Therapeutics
Menlo Ventures
Menlo Ventures investment in Series C - Pliant Therapeutics
Key Employee Changes
Official Site Inspections
http://www.pliantrx.com Semrush global rank: 2.61 M Semrush visits lastest month: 6.86 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Pliant Therapeutics"
Investors & Media - Pliant Therapeutics, Inc.
Feb 13, 2025 Corporate Profile. Pliant Therapeutics is a late-stage biopharmaceutical company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic …See details»
About - Pliant Therapeutics
We are a clinical stage biopharmaceutical company discovering and developing novel therapies for the treatment of fibrosis and related diseases. By leveraging our powerful product …See details»
Leadership - Pliant Therapeutics
Pliant is advancing drug development programs targeting a range of fibrotic diseases, with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway.See details»
Pliant Therapeutics - LinkedIn
Pliant Therapeutics | 12,773 followers on LinkedIn. We are transforming the lives of patients by developing best-in-class treatments for fibrotic diseases. | Pliant Therapeutics is a late-stage ...See details»
Pliant Therapeutics - Crunchbase Company Profile
Pliant Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis.See details»
Press Releases - Pliant Therapeutics, Inc.
Feb 13, 2025 The Investor Relations website contains information about Pliant Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
FAQs - Pliant Therapeutics, Inc.
In these instances contact our Transfer Agent: Standard USPS Computershare P. O. Box 30170 College Station, TX 77842 Overnight Computershare 211 Quality Circle, Suite 210See details»
Pliant Therapeutics (PLRX) Company Profile & Description - Stock …
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United …See details»
Pliant Therapeutics - VentureRadar
"Pliant Therapeutics is a biotechnology company unraveling and targeting the key biological pathways driving fibrosis. By leveraging its powerful product discovery engine, Pliant's mission …See details»
Pliant - 2025 Company Profile, Funding & Competitors - Tracxn
6 days ago Pliant has raised a total funding of $207M over 3 rounds. Its first funding round was on Feb 18, 2016. Its latest funding round was a Series C round on Mar 03, 2020 for $100M. 11 …See details»
Pliant Therapeutics, Inc. (PLRX) - Yahoo Finance
See the company profile for Pliant Therapeutics, Inc. (PLRX) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Bernard Coulie, M.D., Ph.D. - Pliant Therapeutics
Pliant CEO Bernard Coulie, M.D., Ph.D., brings to the company more than 15 years of senior leadership experience and drug development expertise. He joined Pliant from ActoGeniX …See details»
Pliant Therapeutics - Craft
Pliant Therapeutics is a company focused on discovering, developing, and commercializing treatments for fibrotic diseases. By harnessing the therapeutic potential of integrin biology and …See details»
Pliant Therapeutics Provides Corporate Update and Reports Fourth ...
For additional information about Pliant Therapeutics, visit www.pliantrx.com and follow us on Twitter, LinkedIn, Facebook, and YouTube. Forward-Looking Statements Statements …See details»
Pliant Therapeutics, Inc. (PLRX) - Yahoo Finance Canada
See the company profile for Pliant Therapeutics, Inc. (PLRX) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Pliant Therapeutics - Overview, News & Similar companies
Mar 14, 2024 Pliant Therapeutics contact info: Phone number: (650) 481-6770 Website: www.pliantrx.com What does Pliant Therapeutics do? Pliant Therapeutics is a clinical stage …See details»
Pliant Therapeutics: An Activist On Deck - Seeking Alpha
6 days ago Pliant Therapeutics' stock plummeted, but Kevin Tang’s stake raises takeover hopes. Find out why PLRX stock’s cash reserves present a compelling investment.See details»
Pliant Therapeutics Provides Corporate Update and Reports Third …
Ir@pliantrx.com. Pliant Therapeutics, Inc. Condensed Statements of Operations (Unaudited) (In thousands, except number of shares and per share amounts) Three Months Ended September …See details»
Pliant Therapeutics Adopts Limited Duration Stockholder Rights ...
SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that its Board of Directors has unanimously adopted a …See details»
Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 …
SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that following a prespecified data review and …See details»